I was appointed as the President of the Japanese Urological Association (JUA) and Editor-in-Chief of the International Journal of Urology (IJU), the official journal of JUA, in April 2011. The board of Associate Editors has also been renewed with this change.
The Journal was founded in 1994, and during these 18 years it has published almost 3000 distinguished articles of scientific excellence in urology. Since January 2011, IJU has been registered as the official journal of the Urological Association of Asia (UAA).
The present status of IJU is represented as follows: almost 1200 submissions and 221 published articles yearly in monthly issues, 11 189 readers including institutional subscribers worldwide, a mean publish latency of 5.9 months, a recent impact factor of 1.158 and nearly 360 daily online accesses from all over the world. It is now recognized as one of the prestigious journals in the field of urology and nephrology. Such achievements cannot be attained without the continuous and enthusiastic efforts of founders and the following editorial boards.
The journal welcomes submissions from researchers worldwide on clinical and experimental investigation related to urology. The article categories include original articles, case reports, reviews, guidelines, procedures, skills and pitfalls, and letters to the editor. Short communications are a subclass of original articles, with less data but significant implications. In recent times, the journal has published excellent review articles and clinical guidelines. Author benefits include online early articles available online prior to print publication and no charge for publication of color figures. The online system, as well as frequent editorial board meetings, has enabled a shorter latency for publication of papers.
I appreciate the support that IJU continues to garner from the whole urological community, with an increasing number of submissions of high scientific quality from around the world.